CONTACT US
CONTACT US
Home»Modality»Small Molecule Drugs

Bioanalytical Services for Small Molecule Drug Development

Bioanalysis of small molecule drugs is crucial for understanding their pharmacodynamics (PD) and pharmacokinetics (PK), providing detailed insights into how these drugs affect gene and protein expression, which is essential for determining their efficacy, safety, and mechanism of action. Accurate bioanalysis supports the optimization of drug dosing, identification of biomarkers for therapeutic response, and compliance with regulatory standards, ultimately facilitating the development of effective and safe small molecule therapeutics

Our Expertise

While we do not typically analyze small molecules directly, we leverage advanced genomic and proteomic tools to study gene expression and protein expression. Our expertise in technologies such as qPCR, ddPCR, ELISA, MSD, and LC/MS/MS allows us to provide precise and insightful analysis of molecular responses to small molecule drugs. By focusing on gene and protein expression, we offer crucial insights into the pharmacodynamics (PD) of your drug candidates, supporting the successful advancement of your development programs.

Analytical Support Through All Stages of Product Lifecycle

Phase

Technologies

Application

Preclinical

qPCR, ddPCR, ELISA, MSD, Western Blot, LC/MS/MS

  • In vitro efficacy studies
  • Gene Expression Analysis
  • Protein Expression Analysis

Clinical

qPCR, ddPCR, ELISA, MSD, LC/MS/MS

  • Gene Expression Analysis
  • Protein Expression Analysis
  • Biomarker analysis

Have Questions?

To learn more about our services or to discuss your specific project needs, please contact us. We are committed to providing tailored analytical solutions to meet the unique challenges of your small molecule drug development projects.

CONTACT US